The LXRX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the LXRX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The LXRX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View LXRX Detailed Price Forecast - CNN Money | View LXRX Detailed Summary - Google Finance | ||
View LXRX Detailed Summary - Yahoo! Finance | View LXRX Stock Research & Analysis - Zacks.com |
View LXRX Trends & Analysis - Trade-Ideas | View LXRX Major Holders - Barrons | ||
View LXRX Call Transcripts - NASDAQ | View LXRX Breaking News & Analysis - Seeking Alpha | ||
View LXRX Annual Report - CompanySpotlight.com | View LXRX OTC Short Report - OTCShortReport.com | ||
View LXRX Fundamentals - TradeKing | View LXRX SEC Filings - Bar Chart | ||
View Historical Prices for LXRX - The WSJ | View Performance/Total Return for LXRX - Morningstar | ||
View the Analyst Estimates for LXRX - MarketWatch | View the Earnings History for LXRX - CNBC | ||
View the LXRX Earnings - StockMarketWatch | View LXRX Buy or Sell Recommendations - MacroAxis | ||
View the LXRX Bullish Patterns - American Bulls | View LXRX Short Pain Metrics - ShortPainBot.com |
View LXRX Stock Mentions - StockTwits | View LXRX Stock Mentions - PennyStockTweets | ||
View LXRX Stock Mentions - Twitter | View LXRX Investment Forum News - Investor Hub | ||
View LXRX Stock Mentions - Yahoo! Message Board | View LXRX Stock Mentions - Seeking Alpha |
View Insider Transactions for LXRX - SECform4.com | View Insider Transactions for LXRX - Insider Cow | ||
View LXRX Major Holdings Summary - CNBC | View Insider Disclosure for LXRX - OTC Markets | ||
View Insider Transactions for LXRX - Yahoo! Finance | View Institutional Holdings for LXRX - NASDAQ |
View LXRX Stock Insight & Charts - FinViz.com | View LXRX Investment Charts - StockCharts.com | ||
View LXRX Stock Overview & Charts - BarChart | View LXRX User Generated Charts - Trading View |
Lexicon Pharmaceuticals to Host 2024 Investor Day
Posted on Thursday April 18, 2024
Includes Business and Scientific Updates from Lexicon Executives and Leading Medical Experts in Hypertrophic Cardiomyopathy, Type 1 Diabetes and Diabetic Peripheral Neuropathic PainTHE WOODLANDS, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that senior company executives will be joined by leading physicians at the Lexicon 2024 Investor Day on April 22, 2024. The event will be held in New York City from 9:00 a.m. to 12:00 p.m. ET. Business
All You Need to Know About Lexicon (LXRX) Rating Upgrade to Buy
Posted on Tuesday April 16, 2024
Lexicon (LXRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Lexicon Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Posted on Wednesday April 03, 2024
THE WOODLANDS, Texas, April 03, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced Jeff Wade, Lexicon’s president and chief financial officer, Tom Garner, Lexicon’s senior vice president and chief commercial officer, and Craig Granowitz, M.D., Ph.D., Lexicon’s senior vice president and chief medical officer, will participate in a moderated discussion at the 23rd Annual Needham Virtual Healthcare conference Wednesday April 10th, 1:30-2:10pm. A simultaneous webca
Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo
Posted on Monday March 25, 2024
THE WOODLANDS, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that four data presentations related to sotagliflozin, an inhibitor of two sodium glucose transport proteins (SGLT2 and SGLT1), will be delivered during the American College of Cardiology 73rd Annual Scientific Session & Expo being held April 6 - 8, 2024 in Atlanta, Georgia, including results from a post-hoc evaluation of the efficacy of sotagliflozin in reducing stroke events in